HEMISPHERE ENERGY CORP (HME.CA) Stock Fundamental Analysis
TSX-V:HME • CA4236301020
2.38 CAD
+0.08 (+3.48%)
Last: Mar 2, 2026, 07:00 PM
Taking everything into account, HME scores 7 out of 10 in our fundamental rating. HME was compared to 210 industry peers in the Oil, Gas & Consumable Fuels industry. HME scores excellent points on both the profitability and health parts. This is a solid base for a good stock. HME is valued quite cheap, but it does not seem to be growing. With these ratings, HME could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
- In the past year HME was profitable.
- In the past year HME had a positive cash flow from operations.
- Of the past 5 years HME 4 years were profitable.
- In the past 5 years HME always reported a positive cash flow from operatings.
1.2 Ratios
- With an excellent Return On Assets value of 24.66%, HME belongs to the best of the industry, outperforming 97.14% of the companies in the same industry.
- HME's Return On Equity of 38.33% is amongst the best of the industry. HME outperforms 98.57% of its industry peers.
- HME has a better Return On Invested Capital (31.98%) than 100.00% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for HME is significantly above the industry average of 6.66%.
- The last Return On Invested Capital (31.98%) for HME is well below the 3 year average (38.31%), which needs to be investigated, but indicates that HME had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.66% | ||
| ROE | 38.33% | ||
| ROIC | 31.98% |
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
1.3 Margins
- HME has a Profit Margin of 30.81%. This is amongst the best in the industry. HME outperforms 94.76% of its industry peers.
- HME's Profit Margin has improved in the last couple of years.
- HME has a Operating Margin of 42.73%. This is amongst the best in the industry. HME outperforms 92.86% of its industry peers.
- In the last couple of years the Operating Margin of HME has grown nicely.
- With a decent Gross Margin value of 60.82%, HME is doing good in the industry, outperforming 79.52% of the companies in the same industry.
- In the last couple of years the Gross Margin of HME has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 42.73% | ||
| PM (TTM) | 30.81% | ||
| GM | 60.82% |
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so HME is creating value.
- HME has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, HME has more shares outstanding
- Compared to 1 year ago, HME has an improved debt to assets ratio.
2.2 Solvency
- HME has an Altman-Z score of 5.32. This indicates that HME is financially healthy and has little risk of bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 5.32, HME belongs to the top of the industry, outperforming 85.24% of the companies in the same industry.
- HME has a debt to FCF ratio of 0.07. This is a very positive value and a sign of high solvency as it would only need 0.07 years to pay back of all of its debts.
- HME has a Debt to FCF ratio of 0.07. This is amongst the best in the industry. HME outperforms 96.19% of its industry peers.
- HME has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
- The Debt to Equity ratio of HME (0.03) is better than 75.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.07 | ||
| Altman-Z | 5.32 |
ROIC/WACC3.96
WACC8.08%
2.3 Liquidity
- A Current Ratio of 1.41 indicates that HME should not have too much problems paying its short term obligations.
- HME's Current ratio of 1.41 is fine compared to the rest of the industry. HME outperforms 71.43% of its industry peers.
- HME has a Quick Ratio of 1.41. This is a normal value and indicates that HME is financially healthy and should not expect problems in meeting its short term obligations.
- HME has a better Quick ratio (1.41) than 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.41 | ||
| Quick Ratio | 1.41 |
3. Growth
3.1 Past
- The earnings per share for HME have decreased by -9.09% in the last year.
- HME shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 80.04% yearly.
- The Revenue has decreased by -0.77% in the past year.
- Measured over the past years, HME shows a very strong growth in Revenue. The Revenue has been growing by 25.97% on average per year.
EPS 1Y (TTM)-9.09%
EPS 3Y72.84%
EPS 5Y80.04%
EPS Q2Q%-22.22%
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y32.32%
Revenue growth 5Y25.97%
Sales Q2Q%-13.24%
3.2 Future
- Based on estimates for the next years, HME will show a very negative growth in Earnings Per Share. The EPS will decrease by -15.87% on average per year.
- The Revenue is expected to decrease by -7.01% on average over the next years.
EPS Next Y-14.17%
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
EPS Next 5Y-15.87%
Revenue Next Year-5.6%
Revenue Next 2Y-4.78%
Revenue Next 3Y-4.28%
Revenue Next 5Y-7.01%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 7.93, the valuation of HME can be described as very cheap.
- Based on the Price/Earnings ratio, HME is valued cheaply inside the industry as 84.29% of the companies are valued more expensively.
- HME is valuated cheaply when we compare the Price/Earnings ratio to 27.13, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 8.89, the valuation of HME can be described as very reasonable.
- Based on the Price/Forward Earnings ratio, HME is valued a bit cheaper than 80.00% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 28.11. HME is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.93 | ||
| Fwd PE | 8.89 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, HME is valued cheaper than 91.90% of the companies in the same industry.
- 97.62% of the companies in the same industry are more expensive than HME, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.14 | ||
| EV/EBITDA | 3.79 |
4.3 Compensation for Growth
- HME has an outstanding profitability rating, which may justify a higher PE ratio.
- HME's earnings are expected to decrease with -9.18% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 4.42%, HME is a good candidate for dividend investing.
- HME's Dividend Yield is a higher than the industry average which is at 4.11.
- HME's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.42% |
5.2 History
- HME has been paying a dividend for over 5 years, so it has already some track record.
- The dividend of HME decreased in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- HME pays out 60.59% of its income as dividend. This is not a sustainable payout ratio.
DP60.59%
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
TSX-V:HME (3/2/2026, 7:00:00 PM)
2.38
+0.08 (+3.48%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-25 2025-11-25/bmo
Earnings (Next)04-15 2026-04-15/amc
Inst Owners0.71%
Inst Owner ChangeN/A
Ins Owners16.81%
Ins Owner ChangeN/A
Market Cap224.48M
Revenue(TTM)98.24M
Net Income(TTM)30.27M
Analysts84
Price Target2.6 (9.24%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.42% |
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP60.59%
Div Incr Years2
Div Non Decr Years2
Ex-Date02-12 2026-02-12 (0.025)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.91%
Min EPS beat(2)-2.91%
Max EPS beat(2)-2.91%
EPS beat(4)1
Avg EPS beat(4)-1.48%
Min EPS beat(4)-2.91%
Max EPS beat(4)2.8%
EPS beat(8)3
Avg EPS beat(8)-2.87%
EPS beat(12)5
Avg EPS beat(12)1.35%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.89%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)5.99%
Revenue beat(4)3
Avg Revenue beat(4)2.9%
Min Revenue beat(4)-0.21%
Max Revenue beat(4)5.99%
Revenue beat(8)5
Avg Revenue beat(8)0.35%
Revenue beat(12)7
Avg Revenue beat(12)-0.67%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.15%
PT rev (3m)12.09%
EPS NQ rev (1m)11.11%
EPS NQ rev (3m)-9.09%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.51%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-11.2%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)-1.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.93 | ||
| Fwd PE | 8.89 | ||
| P/S | 2.29 | ||
| P/FCF | 5.14 | ||
| P/OCF | 4.04 | ||
| P/B | 2.84 | ||
| P/tB | 2.84 | ||
| EV/EBITDA | 3.79 |
EPS(TTM)0.3
EY12.61%
EPS(NY)0.27
Fwd EY11.25%
FCF(TTM)0.46
FCFY19.46%
OCF(TTM)0.59
OCFY24.76%
SpS1.04
BVpS0.84
TBVpS0.84
PEG (NY)N/A
PEG (5Y)0.1
Graham Number2.38
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.66% | ||
| ROE | 38.33% | ||
| ROCE | 42.48% | ||
| ROIC | 31.98% | ||
| ROICexc | 43.34% | ||
| ROICexgc | 43.34% | ||
| OM | 42.73% | ||
| PM (TTM) | 30.81% | ||
| GM | 60.82% | ||
| FCFM | 44.47% |
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
ROICexc(3y)41.04%
ROICexc(5y)31.02%
ROICexgc(3y)41.04%
ROICexgc(5y)31.02%
ROCE(3y)50.88%
ROCE(5y)39%
ROICexgc growth 3Y12.92%
ROICexgc growth 5Y20.01%
ROICexc growth 3Y12.92%
ROICexc growth 5Y20.01%
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.07 | ||
| Debt/EBITDA | 0.04 | ||
| Cap/Depr | 105.19% | ||
| Cap/Sales | 12.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 104.31% | ||
| Profit Quality | 144.34% | ||
| Current Ratio | 1.41 | ||
| Quick Ratio | 1.41 | ||
| Altman-Z | 5.32 |
F-Score6
WACC8.08%
ROIC/WACC3.96
Cap/Depr(3y)210.69%
Cap/Depr(5y)187.35%
Cap/Sales(3y)20.24%
Cap/Sales(5y)19.51%
Profit Quality(3y)104.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.09%
EPS 3Y72.84%
EPS 5Y80.04%
EPS Q2Q%-22.22%
EPS Next Y-14.17%
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
EPS Next 5Y-15.87%
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y32.32%
Revenue growth 5Y25.97%
Sales Q2Q%-13.24%
Revenue Next Year-5.6%
Revenue Next 2Y-4.78%
Revenue Next 3Y-4.28%
Revenue Next 5Y-7.01%
EBIT growth 1Y-3.75%
EBIT growth 3Y35.09%
EBIT growth 5Y31.88%
EBIT Next Year34.08%
EBIT Next 3Y-0.98%
EBIT Next 5Y-5.77%
FCF growth 1Y130.83%
FCF growth 3Y57.01%
FCF growth 5YN/A
OCF growth 1Y39.86%
OCF growth 3Y36.33%
OCF growth 5Y34.82%
HEMISPHERE ENERGY CORP / HME.CA FAQ
What is the ChartMill fundamental rating of HEMISPHERE ENERGY CORP (HME.CA) stock?
ChartMill assigns a fundamental rating of 7 / 10 to HME.CA.
What is the valuation status for HME stock?
ChartMill assigns a valuation rating of 8 / 10 to HEMISPHERE ENERGY CORP (HME.CA). This can be considered as Undervalued.
Can you provide the profitability details for HEMISPHERE ENERGY CORP?
HEMISPHERE ENERGY CORP (HME.CA) has a profitability rating of 9 / 10.
What is the financial health of HEMISPHERE ENERGY CORP (HME.CA) stock?
The financial health rating of HEMISPHERE ENERGY CORP (HME.CA) is 8 / 10.
Can you provide the dividend sustainability for HME stock?
The dividend rating of HEMISPHERE ENERGY CORP (HME.CA) is 5 / 10 and the dividend payout ratio is 60.59%.